Discovery of metabolites produced by reactions between central carbon metabolites and cysteine that mark inflammatory macrophages

This study identifies a novel class of sulfur-containing metabolites formed by the reaction of cysteine with central carbon intermediates that specifically mark inflammatory macrophages, revealing a previously uncharted metabolic network regulated by Slc7a11 and nitric oxide that is elevated in human inflammatory lesions.

The Gist

Imagine your body's immune system as a highly trained security force. When a threat appears, like a bacteria or a virus, the "guards" (macrophages) switch from a relaxed, resting mode into "Classical Activation" mode (often called M1). In this mode, they go into overdrive: they eat invaders, release powerful weapons, and sound the alarm.

For a long time, scientists knew what these guards did, but they didn't fully understand the unique "fuel" or "chemical signatures" they produced while doing it. Think of it like finding a secret recipe that only a specific chef uses when cooking a spicy dish.

This paper is about discovering a brand-new set of chemical signatures that only appear when these immune guards are in "spicy mode."

Here is the story of how they found them, explained simply:

1. The Mystery of the "Dark Matter" in Metabolism

Scientists have mapped out the main highways of human metabolism (like glycolysis and the TCA cycle) for decades. But there are still "dark alleys" in this map—chemical reactions and molecules that no one has ever seen before. The researchers suspected that when macrophages get angry (activated), they might be making some of these hidden chemicals.

2. The Detective Work: Finding the Clues

The team treated mouse immune cells with a signal to wake them up (LPS + Interferon-gamma). They then took a "chemical snapshot" of the cells.

• The Clue: They found a bunch of new chemical signals that were huge in the "awake" cells but tiny or missing in the "sleeping" cells.
• The Sulfur Trail: They noticed these new chemicals all had a "sulfur" tag (like a specific color on a map). Since the amino acid Cysteine is the main source of sulfur in cells, they guessed these new chemicals were made by Cysteine grabbing onto something else.

3. The "Handshake" Reaction: Cysteine Meets the Fuel

The researchers realized that when macrophages get activated, they change how they burn fuel. They burn sugar (glucose) super fast, and they also tweak their energy factories (the TCA cycle). This causes a buildup of "intermediate" fuel pieces—like half-baked cookies or unfinished engine parts.

The new discovery is that Cysteine (the sulfur carrier) is running around and "shaking hands" with these unfinished fuel pieces.

• The Analogy: Imagine a busy construction site (the activated cell). Usually, the bricks (fuel intermediates) are just sitting there. But when the site gets chaotic (activated), a special worker (Cysteine) starts grabbing these loose bricks and snapping them together into new, temporary structures.
• The Partners: Cysteine grabbed onto:
  • Sugar fragments (from glycolysis).
  • Energy factory parts (like alpha-ketoglutarate and itaconate).

These "handshakes" created a whole new family of molecules that act like a chemical ID badge for an angry macrophage.

4. Why Does This Happen? (The "Why" and "How")

The paper explains three main reasons this happens:

• The Fuel is Piling Up: When the cell goes into overdrive, it produces so much of these fuel intermediates that they start spilling over. Cysteine acts like a sponge, soaking them up.
• The Supply Chain: The cell realizes it needs more Cysteine to handle this mess, so it opens the floodgates to import more of it from the outside.
• The Nitric Oxide Regulator: The cell also produces a gas called Nitric Oxide (NO), which acts like a traffic cop. It speeds up the fuel production and tells the cell to import even more Cysteine, ensuring these new chemicals get made.

5. Is This Just Mouse Stuff? (The Human Connection)

The researchers didn't stop at mice. They looked at human skin samples from patients with a specific inflammatory skin disease called Granuloma Annulare (which is basically a cluster of angry macrophages under the skin).

• The Result: They found these exact same "Cysteine-Fuel Handshake" chemicals in the human patients' skin, and they were much higher in the inflamed spots than in healthy skin.
• The Neutrophils: They even found them in human white blood cells (neutrophils) when those cells were activated. This suggests it's a universal "alarm signal" for many types of immune cells.

6. What Does This Mean? (The Big Picture)

Why should we care about these new chemicals?

• They are Biomarkers: Because they are unique to "angry" immune cells, doctors could potentially use them to detect inflammation or infection earlier and more accurately.
• They might be a "Buffer": The authors suggest these chemicals might be a safety valve. When the cell gets too hot and reactive, these chemicals might be helping to "mop up" dangerous byproducts, protecting the cell from damaging itself.
• They are a "Metabolic Memory": Some of these chemicals stick around longer than the fuel that created them. They might be the cell's way of saying, "Hey, we were under attack recently, keep the defenses up."

Summary Analogy

Think of the immune cell as a kitchen.

• Normal Mode: The chef (metabolism) cooks a steady, predictable meal.
• Activated Mode: The kitchen is in a frenzy. The chef is chopping vegetables (sugar) and stirring pots (TCA cycle) so fast that ingredients are flying everywhere.
• The Discovery: The researchers found that a specific ingredient, Cysteine, is grabbing these flying ingredients and snapping them together into new, temporary gadgets.
• The Significance: These gadgets are the "smoke" coming from the kitchen. If you see these gadgets, you know for sure a fire (inflammation) is happening, even if you can't see the fire itself.

This paper opens a new door, showing us that the immune system doesn't just use known pathways; it creates a whole new, hidden layer of chemistry to manage the stress of fighting infection.

Technical Summary

1. Problem Statement

Despite decades of research mapping central metabolic pathways (glycolysis, TCA cycle), a significant portion of the mammalian metabolome remains unannotated, particularly metabolites unique to specific cellular states. While metabolites like itaconate are known to be specific to the inflammatory "M1" macrophage state, many other state-specific metabolites likely exist in the "dark" parts of the metabolic network. Current metabolomic workflows rely heavily on database matching (e.g., HMDB, KEGG), which fails to identify truly novel compounds that have no prior description. The authors aimed to discover previously unknown metabolites specifically associated with the classical activation of macrophages and elucidate their biochemical origins and biological significance.

2. Methodology

The study employed an integrated, multi-step workflow combining discovery metabolomics, isotopic tracing, in vitro biochemistry, and genetic/pharmacological perturbations:

• Discovery Metabolomics: LC-MS analysis of bone marrow-derived macrophages (BMDMs) under unstimulated, classical (LPS/IFN$\gamma$), and alternative (IL-4/IL-13) activation states. Features were filtered for significant accumulation (>2.5-fold, $p<0.05$) in the classical state.
• Isotopic Tracing:
  • Symmetric Tracing: Cells were cultured with $^{13}$C-labeled glucose, glutamine, or $^{13}$C$_2$-cystine to determine the carbon and sulfur sources of new metabolites.
  • Kinetic Tracing: Time-resolved labeling with U-$^{13}$C-glucose to determine turnover rates and metabolic hierarchy.
• In Vitro Reconstitution: Hypothesized precursors (GAP, DHAP, MGO, $\alpha$-ketoglutarate, itaconate, fumarate) were co-incubated with free cysteine under physiological conditions (pH 7.4, 37°C) to confirm non-enzymatic reaction capabilities.
• Structural Elucidation: High-resolution MS/MS for fragmentation patterns and NMR spectroscopy (1D/2D, HSQC, COSY) to solve the structures of reaction products.
• Genetic and Pharmacological Perturbations: Use of Irg1 (itaconate synthase) and iNOS (nitric oxide synthase) knockout mice, GLUT1 overexpression, glycolysis inhibitors (2-DG), and cystine depletion to validate metabolic dependencies.
• Human Validation: LC-MS analysis of human skin biopsies from patients with Granuloma Annulare (GA) and primary human neutrophils.

3. Key Contributions

• Discovery of Novel Metabolites: Identification of a series of sulfur-containing metabolites that are uniquely abundant in classically activated macrophages. These include adducts formed between cysteine and:
  • Glycolytic intermediates: Glyceraldehyde-3-phosphate (GAP), Dihydroxyacetone phosphate (DHAP), and Methylglyoxal (MGO).
  • TCA cycle intermediates: $\alpha$-Ketoglutarate ($\alpha$KG), Itaconate, and Fumarate.
• Mechanistic Insight: Demonstration that these metabolites are primarily formed via non-enzymatic reactions between free cysteine and reactive carbonyl/carboxyl intermediates of central metabolism.
• Regulatory Network: Elucidation of a regulatory loop where Nitric Oxide (NO) and the NRF2 pathway control cysteine availability (via Slc7a11) and the accumulation of these adducts.
• Methodological Framework: Established a robust pipeline for discovering "dark" metabolites by combining exact mass, natural isotopic distribution (specifically $^{34}$S), and metabolic tracing without relying on pre-existing database matches.

4. Key Results

A. Identification and Specificity

• LC-MS revealed a group of sulfur-containing features (detected via characteristic $^{34}$S isotopic peaks) that accumulate >100-fold in M1 macrophages but are absent in M0 or M2 states.
• Formulas identified include $C_6H_{12}NO_7PS$, $C_8H_{13}NO_6S$, $C_8H_{11}NO_6S$, $C_7H_{11}NO_6S$, $C_6H_{11}NO_4S$, and $C_6H_9NO_3S$.
• Isotopic tracing confirmed these are derived from cysteine (sulfur source) and central carbon metabolites.
  • 6-carbon adducts ($C_6$) derive from 3-carbon glycolytic intermediates (GAP/DHAP).
  • 7-8 carbon adducts ($C_7/C_8$) derive from TCA cycle intermediates ($\alpha$KG, Itaconate, Fumarate).

B. Biochemical Mechanism

• Non-enzymatic Formation: In vitro incubation of cysteine with GAP, DHAP, MGO, $\alpha$KG, itaconate, or fumarate successfully reproduced all identified metabolites.
• Reaction Types:
  • Addition Reactions: Itaconate and fumarate react with cysteine to form S-itaconyl-cysteine and S-succinyl-cysteine.
  • Condensation/Cyclization: GAP, DHAP, and $\alpha$KG react with cysteine to form cyclic or dehydrated adducts. NMR confirmed the cyclic structure of the $\alpha$KG-cysteine adduct (a thiazolidine derivative).
• Kinetics: Glycolysis-derived adducts turnover rapidly (half-life <1 hour), while TCA-derived adducts show slower turnover, suggesting they act as dynamic buffers or signals.

C. Metabolic Regulation

• Cysteine Uptake: Classical activation uniquely upregulates the cystine transporter SLC7A11 (regulated by NRF2), leading to a massive increase in intracellular free cysteine, which is the only amino acid to show such a specific surge.
• NO Regulation:
  • NO (produced by iNOS) promotes the accumulation of glycolysis-derived adducts by inhibiting GAPDH (increasing upstream intermediates) and upregulating SLC7A11.
  • Conversely, NO inhibits the late-stage accumulation of itaconate-derived adducts by inhibiting PDHC, creating a complex temporal regulation.
• Metabolic Stress Response: The levels of these adducts correlate directly with the abundance of their precursors (e.g., DHAP levels during glycolytic upregulation; $\alpha$KG levels during TCA remodeling).

D. Human Relevance

• Granuloma Annulare (GA): These cysteine adducts were detected in human skin biopsies and were significantly elevated in GA lesions (macrophage-rich inflammatory sites) compared to healthy skin.
• Neutrophils: Similar accumulation was observed in human neutrophils upon immune complex stimulation, suggesting this is a broad innate immune response mechanism.

5. Significance

• Biological Function: The authors propose that these adducts serve as a buffering mechanism against non-enzymatic protein post-translational modifications (PTMs). Reactive metabolites (like MGO or itaconate) can modify proteins (e.g., KEAP1), altering signaling. By reacting with free cysteine, the cell may sequester these reactive species, preventing uncontrolled protein damage while potentially generating stable signaling molecules.
• Metabolic Memory: These adducts reflect the metabolic state of the cell (glycolytic flux, TCA remodeling) with greater amplitude and duration than their precursors, potentially acting as a "metabolic memory" of immune activation.
• Biomarker Potential: These novel metabolites serve as specific biomarkers for inflammatory macrophage activation and are elevated in human inflammatory diseases, offering new targets for diagnosis or therapeutic intervention.
• Paradigm Shift: The work highlights that "non-enzymatic" chemistry plays a crucial, regulated role in immune metabolism, expanding the known scope of the mammalian metabolome beyond canonical enzymatic pathways.